Mannatech (NASDAQ:MTEX) is now covered by StockNews.com

Stock research analysts StockNews.com coverage of shares has begun Mannatech (NASDAQ: MTEX – Get a rating) in a report released Monday. The firm has set a “buy” rating on the stock.

Separately, TheStreet upgraded Mannatech from a “c+” rating to a “b-” rating in a research report on Thursday, October 13th.

Mannatech stock performance

Actions MTEX shares opened at $22.40 on Monday. The fifty day simple moving average is $21.55, and the 200 day simple moving average is $21.71. The company has a market cap of $41.64 million, a PE ratio of 9.91 and a beta of 1.12. The company has a current ratio of 1.27, a gearing ratio of 0.74, and a debt-to-equity ratio of 0.01. Mannatech has a 12-month low of $15.49 and a 12-month high of $40.38.

Institutional investors have weighed in on Mannatech

The hedge fund recently bought a new stake in Mannatech stock. IFG Advisory LLC acquired a new position in Mannatech, Incorporated (NASDAQ: MTEX – Get a rating) in the third quarter, according to the company’s most recent filing with the Securities and Exchange Commission. The institutional investor purchased 20,090 shares of the company’s stock, valued at approximately $417,000. IFG Advisory LLC owned 1.05% of Mannatech as of its most recent filing with the Securities and Exchange Commission. Institutional investors and hedge funds own 23.74% of the company’s shares.

About Mannatech

(Get a rating)

Mannatech, Incorporated operates as a global health and wellness company. It develops, markets and sells nutritional supplements; topical skin care and antiaging products; and weight management products. The company mainly sells its products directly, as well as through e-commerce and network marketing channels.

Read more

Get Mannatech Daily news and ratings – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Mannatech and related companies. MarketBeat.com’s FREE Daily E-Newsletter.